DCN Corp develops a patented 9c Protocol that creates uniform metallic nanoparticle coatings for highly sensitive, real‑time diagnostic sensors. These nano‑engineered surfaces can be integrated into handheld or wall‑mounted devices to deliver instant, laboratory‑grade detection and staging of diseases such as cancer and cardiovascular conditions, with low‑cost, scalable manufacturing suitable for point‑of‑care use in low‑resource settings.
Funding
Funding not disclosed
Founders
Product
Problem
Current diagnostic workflows often require centralized laboratory equipment, trained personnel, and lengthy processing times, creating barriers to early disease detection, especially in low‑resource settings. Delays and limited access lead to missed treatment windows and increased patient anxiety.
Solution
DCN Corp. leverages its patented 9c Protocol to create uniform metallic nanoparticle coatings that serve as highly sensitive sensing surfaces for real‑time diagnostics. These nano‑engineered coatings can be integrated into handheld or wall‑mounted devices, enabling instant detection and staging of conditions such as cancer and cardiovascular disease at the point of care. The technology operates at room temperature and atmospheric pressure, allowing scalable production with minimal infrastructure. By coupling the coatings with optical or electrochemical readouts, the system delivers rapid, quantitative results that can be transmitted to telemedicine platforms for immediate clinical review. This approach aims to bring laboratory‑grade accuracy to at‑home and remote environments, improving early intervention and reducing reliance on limited healthcare resources.
Target Audience
Primary customers include diagnostic device manufacturers, healthcare providers seeking point‑of‑care testing solutions, and NGOs or public‑health agencies deploying rapid testing in low‑resource communities.
Features
- 9c Protocol provides precise control of nanoparticle aggregation, yielding reproducible nano‑scale coatings with consistent optical and catalytic properties
- Room‑temperature, atmospheric‑pressure fabrication enables low‑cost, high‑volume manufacturing of sensing surfaces
- Compatibility with multiple detection modalities (SERS, LSPR, electrochemical, colorimetric) for versatile biomarker identification
- Integrated into compact handheld or wall‑mounted devices for instant, on‑site analysis of blood, water, or food samples
- Real‑time data transmission to cloud or telemedicine platforms for rapid clinical decision‑making
- Scalable platform suitable for deployment in low‑ and middle‑income regions with limited laboratory infrastructure